Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Case Report Volume 4 Issue 11

Clinical Outcome of Late Initiation of Antiviral Therapy in Patient with Negative COVID-19 PCR Test

Mohammed M Al-Amri1*, Wael F Alblowi2, Hassan Y Alghar2, Abdulmohsen H Almeffarej3 and Ala J Malhis4

1Department of Internal Medicine, Medical Consultant at King Saud Medical City, Saudi Arabia
2Department of Internal Medicine, Medical Consultant, Allergist and Clinical Immunologist at King Saud Medical City, Saudi Arabia
3Department of Internal Medicine, Resident of internal Medicine at King Saud Medical City, Saudi Arabia
4Pharmaceutical Care Department, Clinical Pharmacist King Saud Medical City, Saudi Arabia

*Corresponding Author: Mohammed M Al-Amri, Department of Internal Medicine, Medical Consultant at King Saud Medical City, Riyadh, Saudi Arabia.

Received: October 13, 2020; Published: November 10, 2020

×

Abstract

  54 Years old Indian diabetic gentleman. Presented to emergency medicine department with one day of shortness of breath, cough and Right sided chest pain. Accompanied with 4 days history of fever, not documented. Patient was desating on Room air (54% oxygen saturation) intubated by ER team. Chest X Ray revealed bilateral peripheral consolidation and patchy infiltrates bilaterally. CT of the chest showed Bilateral lung infiltrates and effusion Plus multi focal ground glass opacities. Patient was investigated for COVID 19, underwent total of 4 swabs. The first swab being probable for COVID 19 and the next 3 sample were negative for COVID 19. Treated with triple antiviral therapy (Ribavirin, Lopinavir/Ritonavir and Interferon beta1b), methylprednisolone and Ceftriaxone. Clinicians should be alert to the COVID 19 infection symptoms even with negative swab result.

Keywords: 2019-nCoV; COVID-19; COVID-19 Management; COVID-19 Treatment; Coronavirus; SARS; SARS-CoV-2

×

Citation

Citation: Mohammed M Al-Amri., et al. “Clinical Outcome of Late Initiation of Antiviral Therapy in Patient with Negative COVID-19 PCR Test". Acta Scientific Medical Sciences 4.12 (2020): 09-12.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor0.851

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 20, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US